Clinical trial

The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip…

NCT00401869 · Ortho Biotech, Inc., Industry · Completed

Key facts

NCT number NCT00401869
Title The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
Official title The Effect of PROCRIT on Hemoglobin and Hematocrit and the Relationship to Postoperative Function, Vigor and Strength in Patients Undergoing Primary Total Joint Arthroplasty: A Randomized, Parallel Group, Open-Label Trial
Lead sponsor Ortho Biotech, Inc., Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Anemia
Intervention type Drug
Interventions Epoetin alfa
Enrollment 289
Start date Feb 1, 1999
Completion Dec 1, 2001
First posted Nov 22, 2006
Last update posted Apr 6, 2010

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies